Obstructive sleep apnoea and type 2 diabetes mellitus: A bidirectional association

The Lancet Respiratory Medicine

Volumn 1, Issue 4, 2013, Pages 329-338

  Aurora, R Nisha ^a   Punjabi, Naresh M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CATECHOLAMINE; GLUCOSE; HEMOGLOBIN; HYDROCORTISONE; INSULIN; INTERLEUKIN 6; LEPTIN; ORAL ANTIDIABETIC AGENT; REACTIVE OXYGEN METABOLITE; RESISTIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; BODY FAT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; CENTRAL SLEEP APNEA SYNDROME; CHEYNE STOKES BREATHING; CHRONIC INFLAMMATION; CLINICAL ASSESSMENT; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; DRUG ACTIVITY; EVIDENCE BASED MEDICINE; EXERCISE; FAT MASS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYDROCORTISONE RELEASE; HYPERCAPNIA; HYPERGLYCEMIA; HYPOPNEA INDEX; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOXEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MULTIDRUG RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; REVIEW; RISK REDUCTION; SCREENING; SLEEP DISORDERED BREATHING; SLEEP QUALITY; SLEEP TIME; SYMPATHETIC TONE; VASOCONSTRICTION; WAKEFULNESS; WEIGHT REDUCTION;

DIABETES MELLITUS, TYPE 2; DISEASE MANAGEMENT; HUMANS; INCIDENCE; INSULIN RESISTANCE; RISK ASSESSMENT; RISK FACTORS; SLEEP APNEA, OBSTRUCTIVE; WORLD HEALTH;

EID: 84880027516     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70039-0     Document Type: Review

References (95)

1. Pelone F, Specchia ML, Veneziano MA, et al. Economic impact of childhood obesity on health systems: a systematic review. Obes Rev 2012, 13:431-440.
2. Reilly JJ, Kelly J Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. Int J Obes 2011, 35:891-898.
3. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E Sleep loss: a novel risk factor for insulin resistance and Type 2 diabetes. J Appl Physiol 2005, 99:2008-2019.
4. Spiegel K, Tasali E, Leproult R, Van Cauter E Effects of poor and short sleep on glucose metabolism and obesity risk. Nat Rev Endocrinol 2009, 5:253-261.
5. Grandner MA, Jackson NJ, Pak VM, Gehrman PR Sleep disturbance is associated with cardiovascular and metabolic disorders. J Sleep Res 2012, 21:427-433.
6. Pyykkonen AJ, Isomaa B, Pesonen AK, et al. Subjective sleep complaints are associated with insulin resistance in individuals without diabetes: the PPP-Botnia Study. Diabetes Care 2012, 35:2271-2278.
7. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(suppl 1):S62-S69. American Diabetes Association.
8. Punjabi NM, Ahmed MM, Polotsky VY, Beamer BA, O'Donnell CP Sleep-disordered breathing, glucose intolerance, and insulin resistance. Respir Physiol Neurobiol 2003, 136:167-178.
9. Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB Snoring as a risk factor for type II diabetes mellitus: a prospective study. Am J Epidemiol 2002, 155:387-393.
10. Elmasry A, Lindberg E, Berne C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001, 249:153-161.
11. Pamidi S, Tasali E Obstructive sleep apnea and type 2 diabetes: is there a link?. Front Neurol 2012, 3:126.
12. Punjabi NM Do sleep disorders and associated treatments impact glucose metabolism?. Drugs 2009, 69(suppl 2):13-27.
13. Aurora RN, Punjabi NM Sleep apnea and metabolic dysfunction: cause or co-relation?. Sleep Med Clin 2007, 2:237-250.
14. West SD, Nicoll DJ, Stradling JR Prevalence of obstructive sleep apnoea in men with type 2 diabetes. Thorax 2006, 61:945-950.
15. Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 2004, 160:521-530.
16. Marshall NS, Wong KK, Phillips CL, Liu PY, Knuiman MW, Grunstein RR Is sleep apnea an independent risk factor for prevalent and incident diabetes in the Busselton Health Study?. J Clin Sleep Med 2009, 5:15-20.
17. Reichmuth KJ, Austin D, Skatrud JB, Young T Association of sleep apnea and type II diabetes: a population-based study. Am J Respir Crit Care Med 2005, 172:1590-1595.
18. Punjabi NM, Polotsky VY Disorders of glucose metabolism in sleep apnea. J Appl Physiol 2005, 99:1998-2007.
19. Cheng N, Cai W, Jiang M, Wu S Effect of hypoxia on blood glucose, hormones, and insulin receptor functions in newborn calves. Pediatr Res 1997, 41:852-856.
20. Raff H, Bruder ED, Jankowski BM The effect of hypoxia on plasma leptin and insulin in newborn and juvenile rats. Endocrine 1999, 11:37-39.
21. Raff H, Bruder ED, Jankowski BM, Colman RJ Effect of neonatal hypoxia on leptin, insulin, growth hormone and body composition in the rat. Horm Metab Res 2001, 33:151-155.
22. Polotsky VY, Li J, Punjabi NM, et al. Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 2003, 552:253-264.
23. Braun B, Rock PB, Zamudio S, et al. Women at altitude: short-term exposure to hypoxia and/or alpha(1)-adrenergic blockade reduces insulin sensitivity. J Appl Physiol 2001, 91:623-631.
24. Larsen JJ, Hansen JM, Olsen NV, Galbo H, Dela F The effect of altitude hypoxia on glucose homeostasis in men. J Physiol 1997, 504(pt 1):241-249.
25. Louis M, Punjabi NM Effects of acute intermittent hypoxia on glucose metabolism in awake healthy volunteers. J Appl Physiol 2009, 106:1538-1544.
26. Oltmanns KM, Gehring H, Rudolf S, et al. Hypoxia causes glucose intolerance in humans. Am J Respir Crit Care Med 2004, 169:1231-1237.
27. Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005, 165:863-867.
28. Liu R, Zee PC, Chervin RD, et al. Short sleep duration is associated with insulin resistance independent of adiposity in Chinese adult twins. Sleep Med 2011, 12:914-919.
29. Lou P, Chen P, Zhang L, et al. Relation of sleep quality and sleep duration to type 2 diabetes: a population-based cross-sectional survey. BMJ Open 2012, 2.
30. Spiegel K, Leproult R, Van Cauter E Impact of sleep debt on metabolic and endocrine function. Lancet 1999, 354:1435-1439.
31. Stamatakis KA, Punjabi NM Effects of sleep fragmentation on glucose metabolism in normal subjects. Chest 2010, 137:95-101.
32. Tasali E, Leproult R, Ehrmann DA, Van Cauter E Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci USA 2008, 105:1044-1049.
33. Hedner J, Ejnell H, Sellgren J, Hedner T, Wallin G Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension?. J Hypertens Suppl 1988, 6:S529-S531.
34. Somers VK, Mark AL, Zavala DC, Abboud FM Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. J Appl Physiol 1989, 67:2095-2100.
35. Somers VK, Mark AL, Zavala DC, Abboud FM Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 1989, 67:2101-2106.
36. Loredo JS, Ziegler MG, Ancoli-Israel S, Clausen JL, Dimsdale JE Relationship of arousals from sleep to sympathetic nervous system activity and BP in obstructive sleep apnea. Chest 1999, 116:655-659.
37. Avogaro A, Toffolo G, Valerio A, Cobelli C Epinephrine exerts opposite effects on peripheral glucose disposal and glucose-stimulated insulin secretion. A stable label intravenous glucose tolerance test minimal model study. Diabetes 1996, 45:1373-1378.
38. Lechin F, van der Dijs B Central nervous system circuitry involved in the hyperinsulinism syndrome. Neuroendocrinology 2006, 84:222-234.
39. Raz I, Katz A, Spencer MK Epinephrine inhibits insulin-mediatedglycogenesis but enhances glycolysis in human skeletal muscle. Am J Physiol 1991, 260(3 pt 1):E430-E435.
40. Polak J, Beamer BA, Punjabi NM Obstructive sleep apnea and glucose metabolism. Sleep apnea: sleep apnea pathogenesis, diagnosis and treatment 2012, Informa Healthcare, London. 2nd edn. A.I. Pack (Ed.).
41. Lavie L Oxidative stress inflammation and endothelial dysfunction in obstructive sleep apnea. Front Biosci 2012, 4:1391-1403.
42. Punjabi NM Sleep apnea and alterations in glucose metabolism. Sleep apnea: implications in cardiovascular and cerebrovascular disease 2012, Informa Healthcare, London. 2nd edn. T.D. Bradley, J.S. Floras (Eds.).
43. de Oliveira Leal V, Mafra D Adipokines in obesity. Clin Chim Acta 2013, 419:87-94.
44. Mantzoros CS, Magkos F, Brinkoetter M, et al. Leptin in human physiology and pathophysiology. Am J Physiol Endocrinol Metab 2011, 301:E567-E584.
45. Marroqui L, Gonzalez A, Neco P, et al. Role of leptin in the pancreatic beta-cell: effects and signaling pathways. J Mol Endocrinol 2012, 49:R9-17.
46. Polotsky VY, Jun J, Punjabi NM Obstructive sleep apnea and metabolic dysfunction. Principles and practices of sleep medicine 2011, 1331. Elsevier Saunders, St Louis. fifth edn. M.H. Kryger, T. Roth (Eds.).
47. Shehzad A, Iqbal W, Shehzad O, Lee YS Adiponectin: regulation of its production and its role in human diseases. Hormones 2012, 11:8-20.
48. Hajer GR, van Haeften TW, Visseren FL Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 2008, 29:2959-2971.
49. Masserini B, Morpurgo PS, Donadio F, et al. Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 2006, 29:700-705.
50. Wolk R, Svatikova A, Nelson CA, et al. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 2005, 13:186-190.
51. Zhang XL, Yin KS, Wang H, Su S Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 2006, 73:73-77.
52. Rajala MW, Obici S, Scherer PE, Rossetti L Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest 2003, 111:225-230.
53. Steppan CM, Brown EJ, Wright CM, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci USA 2001, 98:502-506.
54. Utzschneider KM, Carr DB, Tong J, et al. Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans. Diabetologia 2005, 48:2330-2333.
55. Golbidi S, Badran M, Ayas N, Laher I Cardiovascular consequences of sleep apnea. Lung 2012, 190:113-132.
56. Iftikhar IH, Blankfield RP Effect of continuous positive airway pressure on hemoglobin A(1c) in patients with obstructive sleep apnea: a systematic review and meta-analysis. Lung 2012, 190:605-611.
57. Yang D, Liu Z, Yang H, Luo Q Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis. Sleep Breath 2013, 17:33-38.
58. Hecht L, Mohler R, Meyer G Effects of CPAP-respiration on markers of glucose metabolism in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis. Ger Med Sci 2011, 9:Doc20.
59. Brooks B, Cistulli PA, Borkman M, et al. Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness. J Clin Endocrinol Metab 1994, 79:1681-1685.
60. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011, 365:2277-2286.
61. Einhorn D, Stewart DA, Erman MK, Gordon N, Philis-Tsimikas A, Casal E Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus. Endocr Pract 2007, 13:355-362.
62. Foster GD, Sanders MH, Millman R, et al. Obstructive sleep apnea among obese patients with type 2 diabetes. Diabetes Care 2009, 32:1017-1019.
63. Heffner JE, Rozenfeld Y, Kai M, Stephens EA, Brown LK Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. Chest 2012, 141:1414-1421.
64. Resnick HE, Redline S, Shahar E, et al. Diabetes and sleep disturbances: findings from the Sleep Heart Health Study. Diabetes Care 2003, 26:702-709.
65. Lecube A, Sampol G, Lloberes P, et al. Diabetes is an independent risk factor for severe nocturnal hypoxemia in obese patients. A case-control study. PLoS One 2009, 4:e4692.
66. Bottini P, Redolfi S, Dottorini ML, Tantucci C Autonomic neuropathy increases the risk of obstructive sleep apnea in obese diabetics. Respiration 2008, 75:265-271.
67. Keller T, Hader C, De Zeeuw J, Rasche K Obstructive sleep apnea syndrome: the effect of diabetes and autonomic neuropathy. J Physiol Pharmacol 2007, 58(suppl 5):313-318.
68. Neumann C, Martinez D, Schmid H Nocturnal oxygen desaturation in diabetic patients with severe autonomic neuropathy. Diabetes Res Clin Pract 1995, 28:97-102.
69. Rees PJ, Prior JG, Cochrane GM, Clark TJ Sleep apnoea in diabetic patients with autonomic neuropathy. J R Soc Med 1981, 74:192-195.
70. Hein MS, Schlenker EH, Patel KP Altered control of ventilation in streptozotocin-induced diabetic rats. Proc Soc Exp Biol Med 1994, 207:213-219.
71. Tantucci C, Scionti L, Bottini P, et al. Influence of autonomic neuropathy of different severities on the hypercapnic drive to breathing in diabetic patients. Chest 1997, 112:145-153.
72. Kashine S, Kishida K, Funahashi T, et al. Characteristics of sleep-disordered breathing in Japanese patients with type 2 diabetes mellitus. Metabolism 2010, 59:690-696.
73. Noradina AT, Hamidon BB, Roslan H, Raymond AA Risk factors for developing sleep-disordered breathing in patients with recent ischaemic stroke. Singapore Med J 2006, 47:392-399.
74. Tada T, Kusano KF, Ogawa A, et al. The predictors of central and obstructive sleep apnoea in haemodialysis patients. Nephrol Dial Transplant 2007, 22:1190-1197.
75. Bottini P, Dottorini ML, Cristina CM, Casucci G, Tantucci C Sleep-disordered breathing in nonobese diabetic subjects with autonomic neuropathy. Eur Respir J 2003, 22:654-660.
76. Ficker JH, Dertinger SH, Siegfried W, et al. Obstructive sleep apnoea and diabetes mellitus: the role of cardiovascular autonomic neuropathy. Eur Respir J 1998, 11:14-19.
77. Schober AK, Neurath MF, Harsch IA Prevalence of sleep apnoea in diabetic patients. Clin Respir J 2011, 5:165-172.
78. Tamura A, Kawano Y, Watanabe T, Kadota J Obstructive sleep apnea increases hemoglobin A1c levels regardless of glucose tolerance status. Sleep Med 2012, 13:1050-1055.
79. Aronsohn RS, Whitmore H, Van Cauter E, Tasali E Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes. Am J Respir Crit Care Med 2010, 181:507-513.
80. Dernaika TA, Kinasewitz GT, Tawk MM Effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea. J Clin Sleep Med 2009, 5:103-107.
81. Casellini CM, Vinik AI Clinical manifestations and current treatment options for diabetic neuropathies. Endocr Pract 2007, 13:550-566.
82. Epstein LJ, Kristo D, Strollo PJ, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med 2009, 5:263-276.
83. Peppard PE, Young T, Palta M, Dempsey J, Skatrud J Longitudinal study of moderate weight change and sleep-disordered breathing. JAMA 2000, 284:3015-3021.
84. Newman AB, Foster G, Givelber R, Nieto FJ, Redline S, Young T Progression and regression of sleep-disordered breathing with changes in weight: the Sleep Heart Health Study. Arch Intern Med 2005, 165:2408-2413.
85. Thomasouli MA, Brady EM, Davies MJ, et al. The impact of diet and lifestyle management strategies for obstructive sleep apnoea in adults: a systematic review and meta-analysis of randomised controlled trials. Sleep Breath 2013, published online Jan 30. 10.1007/s11325-013-0806-7.
86. Mirrakhimov AE Physical exercise related improvement in obstructive sleep apnea. Look for the rostral fluid shift. Med Hypotheses 2013, 80:125-128.
87. Inzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012, 35:1364-1379.
88. Jeon CY, Lokken RP, Hu FB, van Dam RM Physical activity of moderate intensity and risk of type 2 diabetes: a systematic review. Diabetes Care 2007, 30:744-752.
89. Weinstock TG, Wang X, Rueschman M, et al. A controlled trial of CPAP therapy on metabolic control in individuals with impaired glucose tolerance and sleep apnea. Sleep 2012, 35:617-625.
90. Monahan K, Redline S Role of obstructive sleep apnoea incardiovascular disease. Curr Opin Cardiol 2011, 6:541-547.
91. Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study. Arch Intern Med 2009, 169:1619-1626.
92. Johansson K, Neovius M, Lagerros YT, et al. Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial. BMJ 2009, 339:b4609.
93. Tuomilehto HP, Seppa JM, Partinen MM, et al. Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. Am J Respir Crit Care Med 2009, 179:320-327.
94. Tuomilehto H, Gylling H, Peltonen M, et al. Sustained improvement in mild obstructive sleep apnea after a diet- and physical activity-based lifestyle intervention: postinterventional follow-up. Am J Clin Nutr 2010, 92:688-696.
95. Artham SM, Lavie CJ, Milani RV, Ventura HO Value of weight reduction in patients with cardiovascular disease. Curr Treat Options Cardiovasc Med 2010, 12:21-35.